BDRX
Biodexa Pharmaceticals
NASDAQ: BDRX · HEALTHCARE · BIOTECHNOLOGY
$3.14
-3.09% today
Updated 2026-04-30
Market cap
$2.14M
P/E ratio
—
P/S ratio
0.58x
EPS (TTM)
$-3.38
Dividend yield
—
52W range
$3 – $97
Volume
2.5M
Biodexa Pharmaceticals (BDRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-64.70%
ROA
-32.80%
Debt/equity
0.04x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2012 | — | $-3.99M | — | — | — |
| 2013 | $147000.00 | $-4.08M | 100.00% | -3,060.54% | -2,778.23% |
| 2014 | $157000.00 | $-8.82M | 100.00% | -4,914.01% | -5,619.11% |
| 2015 | $1.38M | $-10.10M | 94.91% | -733.96% | -734.47% |
| 2016 | $1.32M | $-6.16M | -484.28% | -729.55% | -465.68% |
| 2017 | $989000.00 | $-11.71M | -742.16% | -1,190.70% | -1,183.52% |
| 2018 | $1.94M | $-10.37M | -382.92% | -609.65% | -534.98% |
| 2019 | $674000.00 | $-10.09M | -1,063.65% | -1,679.23% | -1,496.29% |
| 2020 | $343000.00 | $-22.19M | -1,669.10% | -6,717.20% | -6,469.10% |
| 2021 | $578000.00 | $-5.46M | -705.19% | -1,210.73% | -944.64% |
| 2022 | $699000.00 | $-7.66M | -631.19% | -1,277.83% | -1,095.28% |
| 2023 | $381000.00 | $-7.08M | -967.45% | -2,103.41% | -1,858.01% |
| 2024 | $0.00 | $-5.73M | — | — | — |
| 2025 | $0.00 | $-6.24M | — | — | — |